Androgen receptor transactivation assay using green fluorescent protein as a reporter

Analytical Biochemistry

Volumn 373, Issue 2, 2008, Pages 263-271

  Beck, Verena ^a   Reiter, Evelyne ^a,b   Jungbauer, Alois ^a,b  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

Author keywords

5 Dihydrotestosterone (5 DHT); Androgen receptor; Green fluorescent protein (GFP); Radioligand binding; Transactivation

Indexed keywords

DNA; GENES; PROTEINS; SCREENING;

ANDROGEN RECEPTORS; DIHYDROTESTOSTERONE; GREEN FLUORESCENT PROTEIN; RADIOLIGAND BINDING; TRANSACTIVATION;

FLUORESCENCE;

ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTENEDIONE; BETA GALACTOSIDASE; EPITESTOSTERONE; GREEN FLUORESCENT PROTEIN; LEVONORGESTREL; METHYLTESTOSTERONE; PROGESTERONE; TESTOSTERONE;

ARTICLE; ESTROGEN RESPONSIVE ELEMENT; IC 50; LIGAND BINDING; NONHUMAN; PLASMID; PRIORITY JOURNAL; RADIOASSAY; REPORTER GENE; TRANSACTIVATION; YEAST;

EID: 37549066675     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.09.006     Document Type: Article

References (49)

1. Chang C., Saltzman A., Yeh S., Young W., Keller E., Lee H.J., Wang C., and Mizokami A. Androgen receptor: An overview. Crit. Rev. Eukaryot. Gene Expr. 5 (1995) 97-125
2. Kelce W.R., and Wilson E.M. Environmental antiandrogens: Developmental effects molecular mechanisms and clinical implications. J. Mol. Med. 75 (1997) 198-207
3. TM cells. Toxicol. in Vitro 19 (2005) 831-842
4. Colborn T., Vom Saal F.S., and Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101 (1993) 378-384
5. Rosenberg R.S., Grass L., Jenkins D.J.A., Kendall C.W.C., and Diamandis E.P. Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochem. Biophys. Res. Commun. 248 (1998) 935-939
6. Sultan C., Balaguer P., Terouanne B., Georget V., Paris F., Jeandel C., Lumbroso S., and Nicolas J. Environmental xenoestrogens antiandrogens and disorders of male sexual differentiation. Mol. Cell. Endocrinol. 178 (2001) 99-105
7. Eertmans F., Dhooge W., Stuyvaert S., and Comhaire F. Endocrine disruptors: Effects on male fertility and screening tools for their assessment. Toxicol. in Vitro 17 (2003) 515-524
8. Hareng L., Pellizzer C., Bremer S., Schwarz M., and Hartung T. The integrated project ReProTect: A novel approach in reproductive toxicity hazard assessment. Reprod. Toxicol. 20 (2005) 441-452
9. Soto A.M., Maffini M.V., Schaeberle C.M., and Sonnenschein C. Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 15-33
10. Freyberger A., and Ahr H.-J. Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor. Toxicology 195 (2004) 113-126
11. Fang H., Tong W., Branham W.S., Moland C.L., Dial S.L., Hong H., Xie Q., Perkins R., Owens W., and Sheehan D.M. Study of 202 natural synthetic and environmental chemicals for binding to the androgen receptor. Chem. Res. Toxicol. 16 (2003) 1338-1358
12. Szelei J., Jimenez J., Soto A.M., Luizzi M.F., and Sonnenschein C. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138 (1997) 1406-1412
13. TM cells. Toxicol. in Vitro 19 (2005) 335-352
14. Sonneveld E., Jansen H.J., Riteco J.A.C., Brouwer A., and van der Burg B. Development of androgen- and estrogen-responsive bioassays members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol. Sci. 83 (2005) 136-148
15. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: Cellular and molecular biology. Endocrinol. Rev. 20 (1999) 321-344
16. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
17. Gobinet J., Poujol N., and Sultan C. Molecular action of androgens. Mol. Cell. Endocrinol. 198 (2002) 15-24
18. Gelmann E.P. Molecular biology of the androgen receptor. J. Clin. Oncol. 20 (2002) 3001-3015
19. Lee H.J., and Chang C. Recent advances in androgen receptor action. Cell. Mol. Life Sci. 60 (2003) 1613-1622
20. Roy A.K., Tyagi R.K., Song C.S., Lavrovsky Y., Ahn S.C., Oh T.S., and Chatterjee B. Androgen receptor: Structural domains and functional dynamics after ligand-receptor interaction. Ann. N.Y. Acad. Sci. 949 (2001) 44-57
21. Purvis I.J., Chotai D., Dykes C.W., Lubahn D.B., French F.S., Wilson E.M., and Hobden A.N. An androgen-inducible expression system for Saccharomyces cerevisiae. Gene 106 (1991) 35-42
22. Kojima H., Katsura E., Takeuchi S., Niiyama K., and Kobayashi K. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ. Health Perspect. 112 (2004) 524-531
23. Mak P., Young C.Y., and Tindall D.J. A novel yeast expression system to study androgen action. Recent Prog. Horm. Res. 49 (1994) 347-352
24. Michelini E., Leskinen P., Virta M., Karp M., and Roda A. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. Biosens. Bioelectron. 20 (2005) 2261-2267
25. Sohoni P., and Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158 (1998) 327-339
26. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babai D., Portier C.J., and McDonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143 (1997) 205-212
27. Naylor L.H. Reporter gene technology: The future looks bright. Biochem. Pharmacol. 58 (1999) 749-757
28. March J.C., Rao G., and Bentley W.E. Biotechnological applications of green fluorescent protein. Appl. Microbiol. Biotechnol. 62 (2003) 303-315
29. Zimmer M. Green fluorescent protein (GFP): Applications structure and related photophysical behavior. Chem. Rev. 102 (2002) 759-781
30. Heim R., Prasher D., and Tsien R. Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc. Natl. Acad. Sci. USA 91 (1994) 12501-12504
31. Bovee T.F.H., Helsdingen R.J.R., Koks P.D., Kuiper H.A., Hoogenboom R.L.A.P., and Keijer J. Development of a rapid yeast estrogen bioassay based on the expression of green fluorescent protein. Gene 325 (2004) 187-200
32. Lyttle C.R., Damian-Matsumura P., Juul H., and Butt T.R. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists. J. Steroid Biochem. Mol. Biol. 42 (1992) 677-685
33. Routledge E.J., and Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 15 (1996) 241-248
34. Sugawara T., Nakajima A., and Nomura E. Development of a simple screening system for endocrine disruptors. Med. Sci. Monit. 8 (2002) 431-438
35. Jungbauer A., and Beck V. Yeast reporter system for rapid determination of estrogenic activity. J. Chromatogr. B 777 (2002) 167-178
36. Beck V., Unterrieder E., Krenn L., Kubelka W., and Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J. Steroid Biochem. Mol. Biol. 84 (2003) 259-268
37. Graumann K., and Jungbauer A. Agonistic and synergistic activity of tamoxifen in a yeast model system. Biochem. Pharmacol. 59 (2000) 177-185
38. Jisa E., Dornstauder E., Ogawa S., Inoue S., Muramatsu M., and Jungbauer A. Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene. Biochem. Pharmacol. 62 (2001) 953-961
39. Klinge C.M., Risinger K.E., Watts M.B., Beck V., Eder R., and Jungbauer A. Estrogenic activity in white and red wine extracts. J. Agric. Food Chem. 51 (2003) 1850-1857
40. Promberger A., Dornstauder E., Fruhwirth C., Schmid E.R., and Jungbauer A. Determination of estrogenic activity in beer by biological and chemical means. J. Agric. Food Chem. 49 (2001) 633-640
41. Einhauer A., Schuster M., Wasserbauer E., and Jungbauer A. Expression and purification of homogenous proteins in Saccharomyces cerevisiae based on ubiquitin-FLAG fusion. Protein Expr. Purif. 24 (2002) 497-504
42. Brinkmann A.O., Faber P.W., van Rooij H.C.J., Kuiper G.G.J.M., Ris C., Klaassen P., van der Korput J.A.G.M., Voorhorst M.M., van Laar J.H., Mulder E., and Trapman J. The human androgen receptor: Domain structure, genomic organization and regulation of expression. J. Steroid Biochem. 34 (1989) 307-310
43. Roche P., Hoare S., and Parker M. A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol. 6 (1992) 2229-2235
44. Beck V., Pfitscher A., and Jungbauer A. GFP-reporter for a high throughput assay to monitor estrogenic compounds. J. Biochem. Biophys. Methods 64 (2005) 19-37
45. Schiestl R.H., and Gietz R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16 (1989) 339-346
46. Shimamura M., Kodaira K., Kenichi H., Ishimoto Y., Tamura H., and Iguchi T. Comparison of antiandrogenic activities of vinclozolin and d,l-camphorquinone in androgen receptor gene transcription assay in vitro and mouse in utero exposure assay in vivo. Toxicology 174 (2002) 97-107
47. Andersen H.R., Andersson A.M., Arnold S.F., Autrup H., Barfoed M., Beresford N.A., et al. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ. Health Perspect. 107 (1999) 89-108
48. Fang H., Tong W., Perkins R., Soto A.M., Prechtl N.V., and Sheehan D.M. Quantitative comparisons of in vitro assays for estrogenic activities. Environ. Health Perspect. 108 (2000) 723-729
49. Maggiolini M., Vivacqua A., Carpino A., Bonofiglio D., Fasanella G., Salerno M., Picard D., and Ando S. The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells. Mol. Pharmacol. 62 (2002) 1027-1035